Skip to main content

videos

Andrew Evens, DO, MBA, MSc
Videos
02/28/2025
Andrew Evens, DO, MBA, MSc shared the latest updates and therapeutic advancements for the treatment of follicular lymphoma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Andrew Evens, DO, MBA, MSc shared the latest updates and therapeutic advancements for the treatment of follicular lymphoma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Andrew Evens, DO, MBA, MSc...
02/28/2025
Oncology
Andrew Evens, DO, MBA, MSc
Videos
02/28/2025
Andrew Evens, DO, MBA, MSc shared the latest updates and therapeutic advancements for the treatment of follicular lymphoma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Andrew Evens, DO, MBA, MSc shared the latest updates and therapeutic advancements for the treatment of follicular lymphoma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Andrew Evens, DO, MBA, MSc...
02/28/2025
Oncology
Victor Jimenez-Zepeda, MD
Videos
02/24/2025
Victor Jimenez-Zepeda, MD, discusses updates in clinical trials for treatment of smoldering multiple myeloma and monoclonal gammopathy of undetermined significance prior to development of symptomatic multiple myeloma.
Victor Jimenez-Zepeda, MD, discusses updates in clinical trials for treatment of smoldering multiple myeloma and monoclonal gammopathy of undetermined significance prior to development of symptomatic multiple myeloma.
Victor Jimenez-Zepeda, MD,...
02/24/2025
Oncology
Victor Jimenez-Zepeda, MD
Videos
02/24/2025
Victor Jimenez-Zepeda, MD, discusses updates in clinical trials for treatment of smoldering multiple myeloma and monoclonal gammopathy of undetermined significance prior to development of symptomatic multiple myeloma.
Victor Jimenez-Zepeda, MD, discusses updates in clinical trials for treatment of smoldering multiple myeloma and monoclonal gammopathy of undetermined significance prior to development of symptomatic multiple myeloma.
Victor Jimenez-Zepeda, MD,...
02/24/2025
Oncology
Luciano Costa, MD
Videos
02/18/2025
Luciano Costa, MD discusses advancements and updates, including bispecific antibodies and T-cell engagers, for the treatment of patients with R/R multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Luciano Costa, MD discusses advancements and updates, including bispecific antibodies and T-cell engagers, for the treatment of patients with R/R multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Luciano Costa, MD discusses...
02/18/2025
Oncology
Luciano Costa, MD
Videos
02/18/2025
Luciano Costa, MD discusses advancements and updates, including bispecific antibodies and T-cell engagers, for the treatment of patients with R/R multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Luciano Costa, MD discusses advancements and updates, including bispecific antibodies and T-cell engagers, for the treatment of patients with R/R multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Luciano Costa, MD discusses...
02/18/2025
Oncology
Mateo Mejia Saldarriaga, MD
Videos
02/12/2025
Mateo Mejia Saldarriaga, MD discusses the latest trial data on the utilization of various CAR T-cell therapies for patients with relapsed/refractory multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Mateo Mejia Saldarriaga, MD discusses the latest trial data on the utilization of various CAR T-cell therapies for patients with relapsed/refractory multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Mateo Mejia Saldarriaga, MD...
02/12/2025
Oncology
Mateo Mejia Saldarriaga, MD
Videos
02/12/2025
Mateo Mejia Saldarriaga, MD discusses the latest trial data on the utilization of various CAR T-cell therapies for patients with relapsed/refractory multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Mateo Mejia Saldarriaga, MD discusses the latest trial data on the utilization of various CAR T-cell therapies for patients with relapsed/refractory multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.
Mateo Mejia Saldarriaga, MD...
02/12/2025
Oncology
Melissa Alsina, MD
Conference Coverage
02/12/2025
Melissa Alsina, MD discusses quadruplet therapy with the goal of achieving MRD for patients who are transplant-eligible with newly diagnosed multiple myeloma.
Melissa Alsina, MD discusses quadruplet therapy with the goal of achieving MRD for patients who are transplant-eligible with newly diagnosed multiple myeloma.
Melissa Alsina, MD discusses...
02/12/2025
Oncology
Melissa Alsina, MD
Conference Coverage
02/12/2025
Melissa Alsina, MD discusses quadruplet therapy with the goal of achieving MRD for patients who are transplant-eligible with newly diagnosed multiple myeloma.
Melissa Alsina, MD discusses quadruplet therapy with the goal of achieving MRD for patients who are transplant-eligible with newly diagnosed multiple myeloma.
Melissa Alsina, MD discusses...
02/12/2025
Oncology